matrine has been researched along with paclitaxel in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Hong, G; Liu, T; Mao, L; Yang, X; Zhao, L | 1 |
Goto, M; Hsieh, KY; Lee, KH; Liu, LN; Morris-Natschke, SL; Tan, CJ; Yang, XM; Zhao, BY; Zhao, Y | 1 |
Chen, X; Han, H; Han, M; He, C; Hu, J; Lin, F; Lin, H; Luo, Y; Qi, J; Wen, Z; Yang, M; Yang, R; Yang, Y; Yin, T | 1 |
4 other study(ies) available for matrine and paclitaxel
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Design, synthesis and anticancer activity of matrine-1H-1,2,3-triazole-chalcone conjugates.
Topics: Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chalcone; Drug Design; Drug Screening Assays, Antitumor; Fluorouracil; HeLa Cells; Humans; Male; Matrines; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; NIH 3T3 Cells; Quinolizines; Structure-Activity Relationship; Transplantation, Heterologous; Triazoles | 2015 |
Alkaloids from Oxytropis ochrocephala and antiproliferative activity of sophoridine derivatives against cancer cell lines.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Matrines; Molecular Structure; Oxytropis; Quinolizines; Structure-Activity Relationship | 2016 |
Shikonin N-benzyl matrinic acid ester derivatives as novel telomerase inhibitors with potent activity against lung cancer cell lines.
Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Enzyme Inhibitors; G2 Phase Cell Cycle Checkpoints; Humans; Lung Neoplasms; Matrines; Molecular Docking Simulation; Naphthoquinones; Protein Binding; Quinolizines; Telomerase | 2022 |